Belgian Drugmaker UCB to Invest $2B in Factory Near Atlanta

Belgian drugmaker UCB to invest $2B in factory near Atlanta

The expansion would establish the company’s first biologics manufacturing plant in the United States.

UCB picks Georgia for $2B biologics site; AbbVie exec visits China

UCB plans $2B biologics factory in Gwinnett County, GA; AbbVie seeks China partnerships; US drug supply risks from Iran war; multiple manufacturing expansions by Wilmington PharmaTech, Cambrex & others

Georgia Chosen as the Location for UCB’s New U.S. Biologics Manufacturing Facility

UCB has achieved 15 FDA approvals or indication expansions, nine of which were secured in the past three years.

UCB announces $2B investment in Gwinnett County, bringing 330 jobs to Rowen

GWINNETT COUNTY, Ga. — UCB, a global biopharmaceutical company, announced plans to invest $2 billion in Gwinnett County to build its first U.S. biologics manufacturing facility, a project expected to create 330 jobs over the coming years. The facility will be located at Rowen, a mixed-use innovation district focused on global health, agriculture and environmental sustainability. “This decision reflects our confidence in UCB’s long-term growth an…

UCB banks on Georgia for $2bn biologics manufacturing facility - Pharmaceutical Technology

The $2bn site will reside in the same state as UCB’s US HQ in Smyrna, and will produce biologics from the company's portfolio and pipeline.